Page last updated: 2024-08-23

cromolyn sodium and mercaptopurine

cromolyn sodium has been researched along with mercaptopurine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (66.67)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Present, DH; Sachar, DB	1
Auer, IO	1

Reviews

1 review(s) available for cromolyn sodium and mercaptopurine

Article	Year
Immunotherapy in inflammatory bowel disease. The Medical clinics of North America, 1978, Volume: 62, Issue:1 Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cromolyn Sodium; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Metronidazole	1978

Trials

2 trial(s) available for cromolyn sodium and mercaptopurine

Article	Year
Immunotherapy in inflammatory bowel disease. The Medical clinics of North America, 1978, Volume: 62, Issue:1 Topics: Adult; Alkylating Agents; Antimetabolites; Azathioprine; Child; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Cromolyn Sodium; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Metronidazole	1978
[Current status of drug therapy of chronic inflammatory intestinal diseases]. Zeitschrift fur Gastroenterologie, 1983, Volume: 21, Issue:7 Topics: Azathioprine; Clinical Trials as Topic; Colitis, Ulcerative; Cromolyn Sodium; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Mercaptopurine; Prednisone; Pregnancy; Pregnancy Complications; Recurrence; Research; Sulfasalazine	1983

Other Studies

1 other study(ies) available for cromolyn sodium and mercaptopurine

Article	Year
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011

Article

Year

FDA-approved drug labeling for the study of drug-induced liver injury.

Drug discovery today, 2011, Volume: 16, Issue:15-16

Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011